Cargando…
Technologies to advance COVID-19 vaccine equity
Poor countries need vaccine formats with low barriers to manufacture, distribution and administration.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647962/ https://www.ncbi.nlm.nih.gov/pubmed/34873328 http://dx.doi.org/10.1038/s41587-021-01167-0 |
Ejemplares similares
-
COVID-19 vaccine equity in the Americas
Publicado: (2022) -
COVID-19 vaccine equity in the Americas
por: Regional Health– Americas, The Lancet
Publicado: (2022) -
COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021) -
Technology, innovation and health equity
por: Fong, Hildy, et al.
Publicado: (2015) -
Vaccine equity: A fundamental imperative in the fight against COVID-19
Publicado: (2022)